Okazaki Jason A's Form 4 filing
Assembly Biosciences, Inc. (ASMB) · filed Oct 4, 2023
- Accession no.
- 0001209191-23-051888
- Filed
- Oct 4, 2023
- Trade date
- Oct 2-3, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.89K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Okazaki Jason ACIK 0001807214 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2023 | Common Stock | AGrant or awardAcquired | +12,500 | $0.00 | $0 | 177,286 | Direct | |
| Oct 3, 2023 | Common Stock | SSaleDisposed | −2,363 | $0.80 | −$1,890.4 | 174,923 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.